Monday, May 10, 2021

Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India

Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India Vivimed Labs in receipt of Government of India (DGHS) approval to manufacture and market Favipiravir tablets in the strengths of 200 mg and 400 mg under Vivimed’s own brand name ‘Favulous’ across India, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3uBlqGK
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...